文献速递前列腺癌

高危前列腺癌患者接受机器人辅助根治性前列腺切除术联合或不联合辅助治疗后的功能结局与生活质量

Functional Outcomes and Quality of Life in High-risk Prostate Cancer Patients Treated by Robot-assisted Radical Prostatectomy with or Without Adjuvant Treatments.
PubMed 文献 · Eur Urol Oncol · 2024-05-16

基于前瞻性多中心Be-RALP数据库9235例RALP病例,将2336例高危前列腺癌患者与低/中危患者匹配,采用混合模型纵向分析生活质量、排尿功能与勃起功能。结果显示风险分组不能显著预测上述结局,术后治疗(激素和/或放疗)显著预测IIEF-5、性活动与性功能。

要点

  • 风险分组与RALP后功能结局的临床相关下降无关。
  • 术后治疗显著预测IIEF-5、性活动与性功能。
  • 术后治疗降低勃起功能,但生活质量与排尿功能无临床相关变化。

核心结论

  • 风险分组与RALP后功能结局的临床相关下降无关。
  • 观察到的功能结局与生活质量支持考虑对高危前列腺癌行RALP。
  • 术后治疗导致勃起功能指标降低,而生活质量与排尿功能无临床相关变化。
  • 激素治疗似乎对这些结局的负面影响最突出。

研究设计与样本

  • Be-RALP数据库为前瞻性多中心数据库,覆盖2009年至2016年9235例RALP病例。
  • 从9235例患者中,将2336例高危前列腺癌患者与低/中危前列腺癌患者进行匹配。
  • 患者接受单纯RALP或RALP后放疗和/或激素治疗。
  • 采用混合模型纵向分析不同风险组联合或不联合额外治疗的生活质量、排尿功能与勃起功能。

主要发现

  • 风险分组在预测RALP后生活质量、勃起功能或排尿功能方面不显著。
  • 术后治疗(激素和/或放疗)在预测国际勃起功能指数(IIEF-5)、性活动与性功能方面显著。
  • 术后治疗导致勃起功能指标降低,而生活质量与排尿功能无临床相关变化。
  • 激素治疗似乎对这些结局的负面影响最突出。
  • 生活质量在手术后完全恢复,而勃起功能与排尿功能仅部分恢复。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robot-assisted laparoscopic prostatectomy (RALP) is used frequently to treat prostate cancer; yet, prospective data on the quality of life and functional outcomes are lacking. OBJECTIVE: To assess the quality of life and functional outcomes after radical prostatectomy in different risk groups with or without adjuvant treatments. DESIGN, SETTING, AND PARTICIPANTS: The Be-RALP database is a prospective multicentre database that covers 9235 RALP cases from 2009 until 2016. Of these 9235 patients, 2336 high-risk prostate cancer patients were matched with low/intermediate-risk prostate cancer patients. INTERVENTION: Patients were treated with RALP only or followed by radiotherapy and/or hormone treatment. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: We used a mixed-model analysis to longitudinally analyse quality of life, urinary function, and erectile function between risk groups with or without additional treatments. RESULTS AND LIMITATIONS: Risk group was not significant in predicting quality of life, erectile function, or urinary function after RALP. Postoperative treatment (hormone and/or radiotherapy treatment) was significant in predicting International Index of Erectile Function (IIEF-5), sexual activity, and sexual functioning. CONCLUSIONS: Risk group was not linked with clinically relevant declines in functional outcomes after RALP. The observed functional outcomes and quality of life are in favour of considering RALP for high-risk prostate cancer. Postoperative treatment resulted in lower erectile function measures without clinically relevant changes in quality of life and urinary functions. Hormone therapy seems to have the most prominent negative effects on these outcomes. PATIENT SUMMARY: This study investigated the quality of life, and urinary and erectile function in patients with aggressive and less aggressive prostate cancer after surgery only or in combination with hormones or radiation. We found that quality of life recovers completely, while erectile and urinary function recovers only partially after surgery. Aggressiveness of the disease had a minimal effect on the outcomes; yet, postoperative treatments lowered erectile function further.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Devlies W, Silversmit G, Ameye F, et al. Functional Outcomes and Quality of Life in High-risk Prostate Cancer Patients Treated by Robot-assisted Radical Prostatectomy with or Without Adjuvant Treatments. Eur Urol Oncol. 2024. PMID: 38755093. doi:10.1016/j.euo.2024.04.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。